157 related articles for article (PubMed ID: 2939948)
21. Macrophage activation and mobilization in nude mice by Corynebacterium parvum and pyran: a functional and histologic study.
Stinnett JD; Majeski JA
J Surg Oncol; 1980; 14(4):327-32. PubMed ID: 6969333
[TBL] [Abstract][Full Text] [Related]
22. The effect of Corynebacterium parvum on T cell dependent tumor regression.
McBride WH; Peters LJ; Mason KA; Barrow G
J Reticuloendothel Soc; 1980 Feb; 27(2):151-8. PubMed ID: 6965725
[No Abstract] [Full Text] [Related]
23. The in vivo immunosuppressive action of suppressor cells from alloantigen-cyclosporine-treated mice and the capacity of spleen cells to release interleukins and gamma-interferon.
Yoshimura N; Matsui S; Hamashima T; Kita M; Oka T
Transplantation; 1988 Jan; 45(1):157-62. PubMed ID: 2962348
[TBL] [Abstract][Full Text] [Related]
24. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
Shu SY; Chou T; Sakai K
J Immunol; 1989 Jul; 143(2):740-8. PubMed ID: 2738408
[TBL] [Abstract][Full Text] [Related]
25. The effect of hydrocortisone on the immune response of mice treated with Corynebacterium parvum.
Greenberg CS; Dimitrov NV
Clin Immunol Immunopathol; 1976 Mar; 5(2):264-71. PubMed ID: 776469
[No Abstract] [Full Text] [Related]
26. Suppression of murine NK activity induced by Corynebacterium parvum: further characterization and abrogation of suppressor cells.
Milisauskas VK; Cudkowicz G; Nakamura I
Cancer Immunol Immunother; 1986; 21(1):51-7. PubMed ID: 2935247
[TBL] [Abstract][Full Text] [Related]
27. Frequency analysis of augmented CTL production associated with Corynebacterium parvum-induced tumour regression.
Johnson TR; North RJ
Immunology; 1987 Mar; 60(3):361-6. PubMed ID: 3106195
[TBL] [Abstract][Full Text] [Related]
28. Eradication of syngeneic tumor (Meth A fibrosarcoma) from mice by adoptive immunotherapy of immunized spleen cells induced by Corynebacterium parvum-pyridine extract residue.
Mukai K; Horimi T; Orita K
Acta Med Okayama; 1988 Dec; 42(6):301-10. PubMed ID: 3266420
[TBL] [Abstract][Full Text] [Related]
29. The adjuvant effect of Corynebacterium parvum: T-cell dependence of macrophage activation.
Sljivić VS; Watson SR
J Exp Med; 1977 Jan; 145(1):45-57. PubMed ID: 299769
[TBL] [Abstract][Full Text] [Related]
30. Modulation of suppressor mechanisms in allergic contact dermatitis: 2. Inhibition of suppressor T-lymphocytes by Corynebacterium parvum.
Knop J; Riechmann R; Macher E
J Invest Dermatol; 1981 May; 76(5):396-9. PubMed ID: 6453168
[TBL] [Abstract][Full Text] [Related]
31. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
32. Corynebacterium parvum-induced resistance to a methylcholanthrene fibrosarcoma.
Gupta JD; Morahan PS; Kaplan AM
J Reticuloendothel Soc; 1978 Jan; 23(1):1-9. PubMed ID: 627989
[No Abstract] [Full Text] [Related]
33. Organ distribution of Corynebacterium parvum labeled with iodine-125.
Dimitrov NV; Greenberg CS; Denny T
J Natl Cancer Inst; 1977 Feb; 58(2):287-94. PubMed ID: 833877
[TBL] [Abstract][Full Text] [Related]
34. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
Ghaffar A; Cullen RT; Woodruff MA
Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
[TBL] [Abstract][Full Text] [Related]
35. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
Bear HD
Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
[TBL] [Abstract][Full Text] [Related]
36. Immunomodulation of chemically induced fibrosarcoma by Corynebacterium parvum.
Gupta N; Sehgal S; Aikat BK
Indian J Med Res; 1980 Nov; 72():688-95. PubMed ID: 7203570
[No Abstract] [Full Text] [Related]
37. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.
Savary CA; Lotzová E
J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602
[TBL] [Abstract][Full Text] [Related]
38. Radiation response of C3H fibrosarcoma enhanced in mice stimulated by Corynebacterium parvum.
Suit HD; Sedlacek R; Wagner M; Orsi L
Nature; 1975 Jun; 255(5508):493-4. PubMed ID: 1138200
[No Abstract] [Full Text] [Related]
39. Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells.
Chen MF; Suzuki H; Yano S
Anticancer Res; 1992; 12(2):451-6. PubMed ID: 1580562
[TBL] [Abstract][Full Text] [Related]
40. Characterization of Corynebacterium parvum-induced suppressor cells of mouse NK and ADCC activity.
Santoni A; Santoni G; Piccoli M; Herberman RB; Frati L
Immunopharmacol Immunotoxicol; 1990; 12(3):363-87. PubMed ID: 2148342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
